ANTIGENICS INC /DE/ (AGEN) has 64 open-market insider trades by 20 insiders since 2006. The most active filer is Garo H. Armen.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Incyte Corp. | 10% Owner | — | 3 | $65.7M | 2020-06-17 |
| QVT Fund V LP | 10% | — | 1 | $12.5M | 2015-01-09 |
| Garo H. Armen | — | — | 20 | $12.2M | 2026-07-10 |
| Shahzad Malik | Dir | — | 1 | $7.9M | 2015-05-27 |
| Steven J. O'Day | — | — | 1 | $237K | 2025-06-18 |
| Ulf Wiinberg | Dir | — | 2 | $208K | 2023-11-15 |
| Christine M. Klaskin | — | — | 6 | $167K | 2025-06-18 |
| Karen Valentine | CLO | — | 7 | $128K | 2017-12-12 |
| Shalini Sharp | Dir | — | 5 | $119K | 2015-09-28 |
| Kerry Wentworth | VPClinicalReg & Qual | — | 5 | $103K | 2014-02-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Garo H. Armen | — | Buy | $325K | 2024-02-15 |
| Ulf Wiinberg | Director | Buy | $19K | 2023-11-15 |
| Steven J. O'Day | — | Sell | $237K | 2022-01-06 |
| Garo H. Armen | CEO & Chairman | Sell | $1.1M | 2021-09-13 |
| Christine M. Klaskin | — | Sell | $72K | 2021-09-10 |
| Incyte Corp. | 10% Owner | Sell | $1.6M | 2020-06-16 |
Companies that share insiders with AGEN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Incyte Corp. | 10% Owner | Sell | $4.2M | 2020-06-11 |
| Jennifer Buell | Chief Communications Officer | Sell | $12K | 2017-12-12 |
| Christine M. Klaskin | VP & Finance | Sell | $19K | 2017-12-12 |
| Alex Duncan | CTO | Sell | $23K | 2017-12-12 |
| Karen Valentine | CLO | Sell | $29K | 2017-12-12 |
| Ozer Baysal | Chief Commercial Officer | Sell | $13K | 2017-12-12 |
| Garo H. Armen | CEO & Chairman | Buy | $355K | 2017-10-27 |
| Garo H. Armen | CEO & Chairman | Buy | $669K | 2017-04-10 |
| Incyte Corp. | 10% Owner | Buy | $60.0M | 2017-02-14 |